Skip to main content
MEDICAL DEVELOPMENTS INTERNATIONAL LIMITED logo

MEDICAL DEVELOPMENTS INTERNATIONAL LIMITED — Investor Relations & Filings

Ticker · MVP ISIN · AU000000MVP2 LEI · 9845007EAECAOD1U4493 ASX Manufacturing
Open in API
Filings indexed 908 across all filing types
Latest filing 2019-09-24 Annual Report
Country AU Australia
Listing ASX MVP

About MEDICAL DEVELOPMENTS INTERNATIONAL LIMITED

https://medicaldev.com

Medical Developments International Limited specializes in the development and distribution of emergency pain relief and respiratory products. The company's flagship product is Penthrox, a handheld, self-administered inhaler providing rapid-onset, non-opioid analgesia using methoxyflurane. Penthrox is utilized globally by emergency medical services, hospitals, and for procedural pain in various clinical settings. Additionally, the company manufactures a range of respiratory medical devices, including anti-static spacers and asthma management tools designed to optimize medication delivery. The organization focuses on providing portable, effective solutions for acute pain management and respiratory care, catering to healthcare professionals and patients in emergency, surgical, and primary care environments.

Recent filings

Filing Released Lang Actions
Annual Report to Shareholders 76 pages 5.7MB
Annual Report Classification · 100% confidence The document is titled 'FULL YEAR REPORT 2019' and covers the financial year ended 30 June 2019, with detailed financial performance data, operational highlights, clinical and commercial updates, and outlook. It includes comprehensive financial and business information such as net profit, revenue, sales growth, clinical programs, and strategic initiatives. The length is substantial (15,000 characters), indicating it is a full report rather than a brief announcement. The content aligns with an official yearly report covering company activity and full financial performance, which matches the definition of an Annual Report (10-K). There is no indication that this is merely an announcement or a presentation, nor is it a transcript, audit report, or other specific filing type. Therefore, the document should be classified as an Annual Report (10-K).
2019-09-24 English
MVP Roadshow Presentation 18 pages 1.2MB
Annual Report Classification · 95% confidence The document is titled 'Medical Developments International September 2019' and contains detailed information on product development, regulatory progress, clinical trials, sales growth, financial performance, and outlook for the fiscal year 2019 (FY19). It includes financial metrics such as cash receipts, net profit after tax, EBITDA, and dividends, as well as forward-looking statements and disclaimers typical of an annual summary. The length of the document (12,032 characters) and the comprehensive content covering the full fiscal year indicate it is a full annual report rather than a brief announcement or presentation. There is no indication that this is merely an announcement of a report or a certification document. Therefore, the document fits the definition of an Annual Report (10-K). FY 2019
2019-09-04 English
Update - Dividend/Distribution - MVP 4 pages 35.0KB
Notice of Dividend Amount Classification · 100% confidence The document is titled 'Notification of dividend / distribution' and contains detailed information about a dividend payment, including dividend type, record date, payment date, dividend amount, franking details, and dividend reinvestment plan (DRP) specifics. It is an announcement providing shareholders with the dividend amount and payment details rather than a full financial report or other types of filings. The content matches the definition of a Notice of Dividend Amount (DIV). The document length and detail confirm it is not a brief report publication announcement or a regulatory filing. Therefore, the correct classification is DIV.
2019-09-03 English
Preliminary Final Report and Full Year Accounts 76 pages 4.1MB
Annual Report Classification · 95% confidence The document is titled 'Medical Developments International Limited. Appendix 4E Results for Announcement to the Market' and contains detailed financial results for the year ended 30 June 2019, including revenue, profit after tax, earnings per share, dividends, net tangible assets, and a comprehensive Chairman and CEO report. It discusses full year financial performance, operational highlights, clinical and commercial updates, and outlook. The document references the audited Financial Report for the year ended 30 June 2019 and includes extensive financial data and analysis, not just an announcement or summary. The length is substantial (15,000 characters), indicating it is a full report rather than a brief announcement. The presence of detailed financial statements, management discussion, and operational review aligns with the characteristics of an Annual Report (10-K equivalent). Therefore, the document should be classified as an Annual Report (10-K). FY 2019
2019-08-20 English
Dividend/Distribution - MVP 4 pages 34.9KB
Notice of Dividend Amount Classification · 100% confidence The document is titled 'Notification of dividend / distribution' and contains detailed information about a dividend payment including the dividend amount, ex-date, record date, payment date, and details about the Dividend Reinvestment Plan (DRP). It is an announcement specifically about dividend details rather than a full financial report or earnings release. The content matches the description of a Notice of Dividend Amount filing, which announces dividend amounts and payment details to shareholders.
2019-08-20 English
Appendix 4G 11 pages 192.0KB
Governance Information Classification · 95% confidence The document is titled 'Appendix 4G' and references ASX Listing Rules 4.7.3 and 4.10.3, which relate to corporate governance disclosures. It includes a detailed key to disclosures against the ASX Corporate Governance Council Principles and Recommendations for the financial year ended 30 June 2019. The document is a corporate governance statement or a related disclosure form that accompanies the annual report but is not the annual report itself. It does not contain financial statements or management discussion of financial results but focuses on governance practices and compliance with governance recommendations. The document length is 15,000 characters, indicating it is substantive but focused on governance disclosures. According to the filing definitions and rules, this type of document fits best under Governance Information (CGR), which covers reports detailing the company's internal rules, board structure, and governance practices. It is not an announcement of a report (RPA), nor a full annual report (10-K), nor a regulatory filing (RNS) as it is a formal governance disclosure. Therefore, the correct classification is CGR with high confidence.
2019-08-20 English

Browse filings by year

24 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.